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Modern technology has created a vast pool
of chemical pollutants that invade man's en-
vironment daily. The mutagenic, teratogenic,
and carcinogenic potentials of the majority
of these chemicals have not yet been evalu-
ated. It is vital to screen as many of these
substances as is feasible for their genetic
risks, with the ultimate goal of eliminating
the potentially hazardous compounds from
the environment, thereby reducing genetic
damage in man.
In evaluating the genetic hazards of a
chemical to man, consideration must be
given to mutations caused to both somatic
and germinal cells. In the case of mutations
to somatic cells, the primary concern is about
the potential of carcinogenesis-a concern
to the immediate individual. For mutations
to germinal cells, the risks are to the future
population. No test system today is adequate
to truly assess the risk to all types of somatic
and germinal cells.
To evaluate mutagenic effects on germinal
cells, three mammalian test systems are gen-
erally available. These are the dominant-
lethal test (1-4), the specific-locus test (4,
5), and the translocation test (6, 7). Of
these systems, the dominant lethal test has
been more widely accepted and evaluated,
partly because it is less expensive and sim-
pler to perform.
In the dominant-lethal test, rodents are
treated with the chemical agent and then
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mated with untreated partners. In general,
the animal treated is a male because chemi-
cals acting systemically on females may in-
terfere with hormonal status, possibly inter-
fering with the development of normal fe-
tuses, or the chemical may act directly on
the maturing oocyte, causing death other
than by a dominant-lethal mutation (3).
Furthermore, a mutational response in a
male can be studied by mating it to more
than one female at one or different times,
an important point in evaluating the stage
of spermatogenesis affected by the chemical,
while the response in a female can only be
studied in a single pregnancy (3). In most
standard studies, males are treated by acute,
subacute, or chronic exposures and then
mated with untreated females. The females
are replaced each week throughout a com-
plete spermatogenic cycle to ensure testing
of the animal at all stages of spermatogene-
sis. Mated females are sacrificed midway
through the gestation period for examination
of the uteri and for determination of the
number of live and dead embryos. Deaths
are assumed to result from a dominant lethal
mutation.
The basis for using the dominant-lethal
test is that nonviable zygotes can result from
chromosomal damage and rearrangements.
Evidence for this has been provided em-
bryologically and cytogenetically (6, 8). The
primary advantages of using the dominant
lethal test have been described (3, 6, 9) and
are: (1) compared with other tests for meas-
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cells, it is relatively inexpensive; (2) it is
possible to analyze mutational events in all
mammalian germ cells in a reasonable time
period; (3) treatment modes can be of all
types-intraperitoneal, intramuscular, in-
travenous,- oral, inhalation-and of acute,
subacute, or chronic durations; (4) sensitiv-
ity of all stages of spermatogenesis and
oogenesis can be evaluated.
Disadvantages have also been listed for
the dominant lethal test. Some of them are:
(1) nongenetic causes can also cause preim-
plantation loss (3, 9); (2) direct genetic
analysis of mutation is not possible (9); (3)
point- mutagens will probably go undetect-
ed (3, 7, 9), a fact which is particularly sign
ficant, since point mutations are more likely
to be transmitted to the offspring than chro-
mosome aberrations (10); (4) chromosome
breakage cause of dominant lethals-does
not necessarily result in a mutation (3, 9);
(5) significance of the results from treated
females may be questionable, since fetal
death may result from physiological rather
than genetic effects. Therefore, effects on
oogenesis may not be truly evaluated-an
essential consideration (7).
In the specific locus test, wild-type male or
female mice are treated with the test agent
and then mated to partners that are homo-
zygous for several recessive genes. The pro-
geny are examined for the expression of a
recessive gene, which can result only if
one of the dominant genes undergoes a muta-
tion. The phenotypic responses usually evalu-
ated deal with coat color and morphological
characteristics.
In the case of the specific locus test, the
primary drawbacks that have limited its use
are: The large number of animals and ex-
pense involved in performing the test and
the relative insensitivity (11), presumably
resulting primarily from the small number
of genes being examined.
If these disadvantages can be overcome,
there are many advantages to using the
specific-locus test; it measures actual heri-
-table,responses,- since the observed re-
sponses;re transmitted to the progeny (11);
the mutations can be either from point muta-
tions or from major chromosomal aberra-
tions (12); the background level of muta-
tion is extremely low (11).
The translocation test is devised to meas-
ure sterility and heritable semisterility in
F1 progeny of rodents exposed to a test agent.
This is accomplished by treating males or
females with the test agent, mating them
with untreated animals, selecting F, animals
(usually males) for further breeding, and
examining the litter size produced by the
F1 animals. In general, any animal showing
greater than 50% fetal death is considered
semisterile. An animal considered to con-
tain heritable semisterility can be mated fur-
ther for additional data, and the germinal
cells can be examined cytogenetically to
confirm that chromosomal translocations
are present. The semisterility has been
shown to be the result of heritable trans-
locations that can be detected cytogeneti-
cally.
The primary disadvantage of the translo-
cation test is the length of time required
to perform the test (approximately 6
months) and the expense involved. However,
the advantages may prove to compensate for
these drawbacks. The primary advantages
are that it is truly a measure of a heritable
response (13); an animal suspected of being
a mutant can be examined cytogenetically
to confirm that translocations are present
(13-15); the background level is extremely
low, while the positive responses can be
quite high (13).
Various modifications could decrease the
complexity of the translocation test, so that
it will not be a great deal more expensive
than the dominant lethal test without com-
promising the quality of the test.
The current philosophy appears to be that
the dominant lethal test should be used in
a general screening program. However, since
the sensitivity of the dominant-lethal test
(as well as the translocation and specific-
locus test) is much less than with simpler
organisms (9, 10), it seems logical that these
tests be relegated to a second phase in the
evaluation of chemical agents-that is, to
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shown to have an effect on the genome in
a prescreen system having the greatest level
of sensitivity. If the function of mammalian
test system i.e., to evaluate the genetic ef-
fects of a chemical on germinal cells, were a
secondary rather than a primary screen, the
additional costs of the specific locus or trans-
location tests would not be as significant.
A general mutagenic evaluation system
that takes all these points into consider-
ation might be as follows: (1) a decision
process to determine which compounds should
be tested; (2) a presumptive screen to estab-
lish further testing priorities, and (3) ex-
tensive mammalian testing.
A decision process to determine which
compounds should be tested would evaluate
(8, 10): the extent of human exposure, a
knowledge of the genetic effect of the agent,
structural relationship to known mutagens,
and the potential of any metabolites causings
mutagenesis.
In presumptive screening to establish fur-
ther testing priorities, the most sensitive
system available would be used to determine
whether there is a potential for an effect on
the genome. Potential for metabolic activa-
tion should be used. The systems to be used
could include the host-mediated assay with
microbial cells (16, 17), the host-mediated
assay with mammalian cells (18), mammal-
ian cells in tissue culture combined with a
metabolic activation system (19), and iv
vitro microbial studies with the use of a
metabolic activation system (20, 21).
Extensive mammalian testing, including
a translocation or a specific-locus test would
provide as much information as possible for
extrapolation to man. The route of admin-
istration of the test material would be done
on a chronic basis. In addition to tests of
germinal cell effects, studies on somatic cells
should also be performed (e.g., tissue culture
and cytogenetic studies).
Because of the limitations described for
the dominant lethal test, it certainly appears
that the specific locus test or the transloca-
tion- test would be more meaningful when
discussing relevance to man. HEowever, the
need remains to conduct definitive studies
on these tests to establish levels of sensi-
tivity and correlations with other test sys-
tems. Studies such as those described by
Ehling (11), where comparative results be-
tween the specific-locus test and the domin-
ant-lethal test were made, and those perform-
ed by Generoso (13) on the translocation
test must be performed. In Ehling's (11)
studies, a comparison was made between
methyl methanesulfonate (MMS), ethyl
methanesulfonate (EMS), N-methyl-N'-ni-
tro-N-nitrosoguanidine (MNNG), isopropyl
methanesulfonate (iPMS), n-propyl methane-
sulfonate, triethylenemelamine (TEM), and
2-methoxy-6-chloro-9-[3-ethyl-2-chloroethyl)
amino propylamino]acridine dihydrochloride
(ICR-170). In general, he found a lower
level of sensitivity in the specific locus test
than in the dominant lethal test. Generoso
(13) showed that the translocation test was
more sensitive in detecting an ad-
verse effect for EMS than the dominant-
lethal test. A dose of 150 mg/kg was required
to induce a detectable response in the dom-
inant-lethal test, while 50 mg/kg was posi-
tive in the translocation test. Also of ex-
treme significance was the fact that in the
negative controls, no translocations were
found in the 1102 F1 males tested, while
98 F1 males treated with 200 mg/kg of EMS
33 showed positive responses. This indicates,
therefore, that extremely low background
frequencies exist and that significantly high
positive responses occur. Definitive studies
such as these two must be conducted. In these
studies, consideration should also be given
to routes of administration more relevant
to man, such as the oral route or inhalation,
and to the pharmacological question of
whether the compounds actually reach the
sites being tested-in this case, the germinal
cells.
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